title: No consistent bioenergetic defects in presynaptic nerve terminals isolated from mouse models of Alzheimer's disease.
abstract: Depressed cortical energy supply and impaired synaptic function are predominant associations of Alzheimer's disease (AD). To test the hypothesis that presynaptic bioenergetic deficits are associated with the progression of AD pathogenesis, we compared bioenergetic variables of cortical and hippocampal presynaptic nerve terminals (synaptosomes) from commonly used mouse models with AD-like phenotypes (J20 age 6 months, Tg2576 age 16 months, and APP/PS age 9 and 14 months) to age-matched controls. No consistent bioenergetic deficiencies were detected in synaptosomes from the three models; only APP/PS cortical synaptosomes from 14-month-old mice showed an increase in respiration associated with proton leak. J20 mice were chosen for a highly stringent investigation of mitochondrial function and content. There were no significant differences in the quality of the synaptosomal preparations or the mitochondrial volume fraction. Furthermore, respiratory variables, calcium handling, and membrane potentials of synaptosomes from symptomatic J20 mice under calcium-imposed stress were not consistently impaired. The recovery of marker proteins during synaptosome preparation was the same, ruling out the possibility that the lack of functional bioenergetic defects in synaptosomes from J20 mice was due to the selective loss of damaged synaptosomes during sample preparation. Our results support the conclusion that the intrinsic bioenergetic capacities of presynaptic nerve terminals are maintained in these symptomatic AD mouse models.
authors.affiliation: Buck Institute Research on Aging, Novato, California 94945, USA. swchoi.phd@gmail.com
authors.forename: Sung W
authors.initials: SW
authors.lastname: Choi
authors.forename: Akos A
authors.initials: AA
authors.lastname: Gerencser
authors.forename: Ryan
authors.initials: R
authors.lastname: Ng
authors.forename: James M
authors.initials: JM
authors.lastname: Flynn
authors.forename: Simon
authors.initials: S
authors.lastname: Melov
authors.forename: Steven R
authors.initials: SR
authors.lastname: Danielson
authors.forename: Bradford W
authors.initials: BW
authors.lastname: Gibson
authors.forename: David G
authors.initials: DG
authors.lastname: Nicholls
authors.forename: Dale E
authors.initials: DE
authors.lastname: Bredesen
authors.forename: Martin D
authors.initials: MD
authors.lastname: Brand
mesh_terms: D000375:Aging / Q000502:physiology; D000544:Alzheimer Disease / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000502:physiology; D020013:Calcium Signaling / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology*; D005260:Female; D006801:Humans; D007202:Indicators and Reagents; D008297:Male; D008564:Membrane Potentials / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D008928:Mitochondria / Q000378:metabolism / Q000648:ultrastructure; D010101:Oxygen Consumption; D017729:Presynaptic Terminals / Q000378:metabolism / Q000502:physiology*; D013574:Synaptosomes / Q000378:metabolism / Q000648:ultrastructure
chemical_list: D007202:Indicators and Reagents; D002118:Calcium